SpecialSituationsFund184

You may have missed

Immunovant Announces Proposed Offering of $300 Million of Common Stock

Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer

Rapport Financier Semestriel 30 Juin 2023 PHAXIAM

Pacira BioSciences Announces Leadership Succession Plan

Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA Nephropathy (IIGANN 2023)

error: Content is protected !!